| 2023 |
Parathyroid Hormone Related Protein (PTHrP)-Associated Molecular Signatures in Tissue Differentiation and Non-Tumoral Diseases |
Review essay (rassegna critica) |
Vai |
| 2023 |
Natural Anticancer Peptides from Marine Animal Species: Evidence from In Vitro Cell Model Systems |
Review essay (rassegna critica) |
Vai |
| 2023 |
In Vitro Cytotoxic Effect of Aqueous Extracts from Leaves and Rhizomes of the Seagrass Posidonia oceanica (L.) Delile on HepG2 Liver Cancer Cells: Focus on Autophagy and Apoptosis |
Articolo in rivista |
Vai |
| 2022 |
Parathyroid hormone-related protein (PTHrP)-dependent modulation of gene expression signatures in cancer cells |
Articolo in rivista |
Vai |
| 2021 |
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) |
Review essay (rassegna critica) |
Vai |
| 2019 |
Mid-region parathyroid hormone-related protein is a genome-wide chromatin-binding factor that promotes growth and differentiation of HB2 epithelial cells from the human breast |
Articolo in rivista |
Vai |
| 2017 |
Jay Amin Hydroxamic Acid (JAHA), a histone deacetylase inhibitor with cytotoxic activity and the property to increase DNA repair of triple-negative MDA-MB231 breast cancer cells. |
Poster pubblicato in volume |
Vai |
| 2017 |
Molecular Signatures Associated with Treatment of Triple-Negative MDA-MB231 Breast Cancer Cells with Histone Deacetylase Inhibitors JAHA and SAHA |
Articolo in rivista |
Vai |
| 2016 |
Biological effect of a hybrid anticancer agent based on kinase and histone deacetylase inhibitors on triple-negative (MDA-MB231) breast cancer cells |
Articolo in rivista |
Vai |
| 2015 |
The Histone Deacetylase Inhibitor JAHA Down-Regulates pERK and Global DNA Methylation in MDA-MB231 Breast Cancer Cells |
Articolo in rivista |
Vai |
| 2015 |
Effect of conditioned media from osteo- and adipo-differentiating mesenchymal stem cells on triple negative MDA-MB231 breast cancer cells |
Abstract in rivista |
Vai |
| 2015 |
Cytotoxicity of the Urokinase-Plasminogen Activator Inhibitor Carbamimidothioic Acid (4-Boronophenyl) Methyl Ester Hydrobromide (BC-11) on Triple-Negative MDA-MB231 Breast Cancer Cells |
Articolo in rivista |
Vai |
| 2015 |
The conditioned medium from osteo-differentiating human mesenchymal stem cells affects the viability of triple negative MDA-MB231 breast cancer cells |
Articolo in rivista |
Vai |
| 2014 |
The effect of the HDACi JAHA on DNA methylation of breast cancer cells by down-regulating DNMT1 through ERK signaling |
Abstract in atti di convegno pubblicato in volume |
Vai |
| 2014 |
Biological effect of an hybrid anticancer agent based on kinase and histone deacetylase inhibitor on breast cancer cells |
Abstract in atti di convegno pubblicato in volume |
Vai |
| 2014 |
Gene and protein signatures associated to treatment of MDA-MB231 breast cancer cells with JAHA, a novel histone deacetylase inhibitor |
Abstract in atti di convegno pubblicato in volume |
Vai |
| 2014 |
Synthesis of hybrid anticancer agents based on kinase and histone deacetylase inhibitors |
Articolo in rivista |
Vai |
| 2013 |
Effect of conditioned media from osteo- and adipodifferentiating mesenchymal stem cells on triple negative MDA-MB231 breast cancer cells |
Poster pubblicato in volume |
Vai |
| 2013 |
Effect of transfection with PLP2 antisense oligonucleotides on gene expression of cadmium-treated MDA-MB231 breast cancer cells |
Articolo in rivista |
Vai |
| 2013 |
Effetto citotossico di un nuovo inibitore delle deacetilasi istoniche, JAHA, su cellule di tumore mammario umano triplo negativo |
Abstract in atti di convegno pubblicato in volume |
Vai |
| 2013 |
PTHrP in differentiating human mesenchymal stem cells: transcript isoform expression, promoter methylation, and protein accumulation |
Articolo in rivista |
Vai |
| 2013 |
JAHA, a novel histone deacetylase inhibitor: cytotoxic effect on triple-negative breast cancer cells |
Abstract in atti di convegno pubblicato in volume |
Vai |
| 2012 |
JA47, a new histone deacetylase inhibitor that induces cytotoxic effects on triple-negative MDA-MB231 breast cancer cells in vitro |
Abstract in atti di convegno pubblicato in volume |
Vai |
| 2012 |
Cytotoxic effects induced by JA47, a novel histone deacetylase inhibitor (HDACi), on MDA-MB231 breast cancer cells |
Abstract in atti di convegno pubblicato in volume |
Vai |
| 2012 |
Cytotoxic effects of Jay Amin hydroxamic acid (JAHA), a ferrocene-based class I histone deacetylase inhibitor, on triple-negative MDA-MB231 breast cancer cells |
Articolo in rivista |
Vai |
